Title  | Date  | Price |
|---|
World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024
| Jul 2009 |
£1,499 |
Insulin Delivery Devices Market Analysis and Future Forecast
| Jun 2009 |
£520 |
Global Diabetes Market
| Jun 2009 |
£3,965 |
The Toolkit for Diabetes MSL Programs
| May 2009 |
£4,760 |
Diabetes, Metabolic Syndrome and Cardiovascular Disease
| Apr 2009 |
£2,105 |
Blood Glucose Testing and Diabetes Management
| Apr 2009 |
£2,105 |
Future of the Diabetes Care Devices Market to 2015
| Mar 2009 |
£2,135 |
Diabetes Drug Discoveries 2009: what the future holds
| Feb 2009 |
£795 |
World Diabetes Market Analysis 2009-2023
| Feb 2009 |
£1,499 |
China Diabetes Drug Market Report
The Chinese Hospital Cancer Drug Utilization
| Jan 2009 |
£4,950 |
Opportunities Assessment for Diabetes Therapeutics: South Korea
| Dec 2008 |
£3,660 |
European Diabetes Diagnostics Market
| Dec 2008 |
£3,965 |
Opportunities Assessment for Diabetes Therapeutics Market-Taiwan
| Dec 2008 |
£3,660 |
Strategic Analysis of the South African HMI Markets
| Dec 2008 |
£3,660 |
Opportunities Assessment for Diabetes Therapeutics - Australia
| Dec 2008 |
£3,660 |
Diabetes Drug Pipeline
Competitor Analysis
| Nov 2008 |
£1,085 |
Cannabinoid CB1 receptor antagonists
Competitor Analysis
| Nov 2008 |
£115 |
Emerging Diabetes Drugs
Competitor Analysis
| Nov 2008 |
£540 |
Sodium-dependent glucose (co-) transporter (SGLT) Inhibitors
Competitor Analysis
| Nov 2008 |
£90 |
Dipeptidyl peptidase IV (DPP-IV) Inhibitors
Competitor Analysis
| Nov 2008 |
£135 |
Stakeholder Opinions: Diabetic Renal Disease
| Nov 2008 |
£2,315 |
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists
Competitor Analysis
| Nov 2008 |
£270 |
GLP-1 Receptor Agonists
Competitor Analysis
| Nov 2008 |
£180 |
Insulin
Competitor Analysis
| Oct 2008 |
£360 |
Innovations in the Management of Diabetes
Next generation treatments and market dynamics
| Jun 2008 |
£1,215 |
Strategic Analysis of the Kenyan Diabetes Markets
| Apr 2008 |
£4,575 |
Brazil Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Japan Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Belgium Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Netherlands Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Spain Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Italy Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Egypt Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Mexico Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
South Africa Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
UK Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Israel Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Republic of Korea Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Europe Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
South & Central America Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Middle East & Africa Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Germany Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Australia Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Asia Pacific Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
North America Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Canada Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
US Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Global Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£2,475 |
France Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Argentina Diabetic/Diabetes Care Devices Industry Report
| Mar 2008 |
£1,855 |
Advances and Emerging Trends in Diabetes Monitoring Technologies (Technical Insights)
| Mar 2008 |
£3,965 |
Diabetes Therapies & Diagnostics: Global Markets
| Jan 2008 |
£2,955 |
Stakeholder Insight: Diabetes
| Dec 2007 |
£9,270 |
The World Diabetes Market, 2006-2012, 2017, 2025
A Key Pharmaceutical Market of the Future
| Oct 2007 |
£1,499 |
Pipeline Insight: Antidiabetics - Insulins
| Sep 2007 |
£5,870 |
Diabetes and Diabetic Complications
Major World Markets, 3rd Ed.
| Mar 2007 |
£2,435 |
Stakeholder Insight: Atherosclerosis
HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment
| Dec 2006 |
£8,070 |
Commercial and Pipeline Perspectives: Obesity
Lack of Reimbursement Limits Market Potential
| Dec 2006 |
£6,950 |
Stakeholder Insight: Atrial Fibrillation
Limited efficacy and poor safety lead to bleak outlook
| Oct 2006 |
£8,070 |
Pipeline Insight: Insulins
Inhalable insulins unlikely to become blockbusters
| Sep 2006 |
£6,950 |
Commercial Insight: Antihypertensives
New challenges for a maturing market
| Sep 2006 |
£8,070 |
Global Diabetes Market; The
Therapeutics, Diagnostics and Complications
| Aug 2006 |
£1,525 |
Inhaled Insulin
A Market Briefing
| Jul 2004 |
£545 |
Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia
Growth opportunities in fragmented markets
| Nov 1999 |
£2,315 |
previous
